Zobrazeno 1 - 10
of 585
pro vyhledávání: '"hepatic angiosarcoma"'
Autor:
Toshiki Entani, Kazuto Tajiri, Akira Noguchi, Aiko Murayama, Nozomu Muraishi, Yuka Hayashi, Ichiro Yasuda
Publikováno v:
Case Reports in Gastroenterology, Vol 17, Iss 1, Pp 309-315 (2023)
An 80-year-old Japanese man presented to our hospital with intra-abdominal hemorrhage due to a ruptured liver tumor. Transcatheter arterial embolization (TAE) temporarily achieved hemostasis, but he died following re-rupture 4 days later. Based on au
Externí odkaz:
https://doaj.org/article/e69eb215c50a4c0fa13573bf8964cb08
Autor:
Feiqian Wang, Kazushi Numata, Hua Liang, Hiromi Tsuchiya, Litao Ruan, Mikiko Tanabe, Xiaofang Bai
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEnhanced imaging techniques have the overwhelming advantages of being noninvasive and sensitive enough to evaluate the microcirculation of lesions, thus making them accurate in the diagnosis of hepatic lesions. Unfortunately, there is very
Externí odkaz:
https://doaj.org/article/fb8daebda3d149c6b624bb2d714e459f
Autor:
Anagha Deshpande, Javier Munoz, Katalin Kelemen, Vrushali Dabak, Amr Hanbali, Razelle Kurzrock
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 56-58 (2023)
Primary splenic or hepatic angiosarcomas are ultra-rare and aggressive malignancies associated with poor prognosis. The mainstay treatments are surgical resection and chemotherapy. We report a case of angiosarcoma in a 50-year-old woman who presented
Externí odkaz:
https://doaj.org/article/8e06bad67679485d8fdfb563e1d7cf3c
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Primary hepatic angiosarcoma (PHA), a rare soft tissue tumor, accounts for only 2% of all liver malignancies. Pathologically challenging, PHA is difficult to be distinguished from other malignancies with ultrasound, Computed Tomography (CT), or Magne
Externí odkaz:
https://doaj.org/article/1ccca877549a44fd8a56ddfebaa9e128
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPrimary hepatic angiosarcoma (PHA) is a rare malignant tumor of mesothelial tissue origin in the liver. The diagnosis of PHA relies on pathology, and it is frequently misdiagnosed as multiple hepatic hemangioma. Noncirrhotic portal hyperten
Externí odkaz:
https://doaj.org/article/0eac626f0d1646e78815725b5cd4b184
Autor:
Ziyu Tang, master degree, Hong Hu, bachelor's degree, Yunguo Liao, master degree, Chao Li, master degree, Xing Deng, master degree, Shixiang Qiu, master degree
Publikováno v:
Radiology Case Reports, Vol 16, Iss 11, Pp 3354-3358 (2021)
Hepatic angiosarcoma is a rare disease, and hepatic hemangiosarcoma with Kasabach-Merritt syndrome (KMS) is even rarer. Although there have been several reports about KMS caused by hepatic angiosarcoma, there has been no mention of successful treatme
Externí odkaz:
https://doaj.org/article/2cfb184f00ae4c44b73373f64cb92376
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Case Reports in Gastroenterology, Vol 14, Iss 1, Pp 137-149 (2020)
Primary hepatic angiosarcoma (PHA) is a rare mesenchymal liver tumor, accounting for 0.1–2% of primary liver malignancies. The clinical presentations of PHA are variable, from asymptomatic to liver failure or complicated with tumor rupture. The dia
Externí odkaz:
https://doaj.org/article/c1e160ed1b1e41c7827ee6bfc77295d5
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Purpose Primary hepatic angiosarcoma is a very rare and highly malignant tumor with poor prognosis. It is difficult to diagnose because of the lack of typical clinical features, and the treatment protocols for PHA are also not clear. Therefo
Externí odkaz:
https://doaj.org/article/b5c9103f08e546e2868d554bed6b8cca